Login / Signup

Aspirin for primary cardiovascular disease prevention: time to re-evaluate guidelines?

Rahul D BarmanrayPeter Shane Hamblin
Published in: Internal medicine journal (2019)
Keyphrases
  • cardiovascular disease
  • cardiovascular events
  • low dose
  • clinical practice
  • type diabetes
  • antiplatelet therapy
  • cardiovascular risk factors
  • anti inflammatory drugs
  • atrial fibrillation